APT Medical Inc. Class A 688617

SSE · China · Health Technology

CNY 248.25+8.22 (+3.42%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

APT Medical Inc. Class A 688617

SSE · China · Health Technology

CNY 248.25+8.22 (+3.42%)

Market closed· Sep 30, 2026, 7:00 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

+0.51% · 6MFull-screen chart

Open CNY 239.50High CNY 251.50Low CNY 238.79Close CNY 248.25Volume 1.70M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 240.03
Day range: CNY 238.79 – CNY 251.50
52-week range: CNY 176.28 – CNY 337.20
Volume: 1.70M
Market cap: CNY 35.13B
P/E (TTM): 37.6
Dividend yield (annualized): 0.40%
Next earnings date: 2026-10-29
Avg. volume (1Y): 1.35M

Performance

1 week

+1.10%

1 month

+1.26%

3 months

+27.32%

6 months

-2.57%

Year to date

-2.74%

1 year

-21.30%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Medical Specialties
Country: China
Exchange: SSE
Shares outstanding: 139.23M
Employees: 3,118
ISIN: CNE100004C45
Beta: 0.32

Technical view

Above averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceMar 16, 2026

KLN Named Full-line Distributor for APT Medical's Coronary Intervention Products in Hong Kong

KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce that its healthcare subsidiary, KLN Medical Limited ('KLN Medical'), is now the full-line distributor for APT Medical Inc.'s ('APT Medical'; Stock Code 688617.SH) coronary intervention products in Hong Kong. KLN Medical will promote and distribute APT Medical's full coronary intervention portfolio while providing clinical application training, after-sales support and logistics services. This collaboration aims to stre

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.